ROS production is required for follicle-stimulating hormone-induced Nrf2 activation in human epithelial ovarian cancer cells
- Author:
- No author available
- Journal Title:
- Academic Journal of Second Military Medical University
- Issue:
- 9
- DOI:
- 10.3724/SP.J.1008.2012.00935
- Key Word:
- 卵巢肿瘤;促卵泡激素;活性氧;红系衍生的核因子2相关因子2
Abstract： 目的 通过观察促卵泡激素(FSH)、活性氧(ROS)及其特异性抑制剂对卵巢癌细胞中红系衍生的核因子2相关因子2(nuclear factor-erythroid 2-related factor-2,Nrf2)表达的影响,探讨FSH是否通过ROS途径调控卵巢癌细胞Nrf2的表达.方法 (1)采用免疫组织化学方法检测Nrf2在卵巢癌良恶性组织中的表达.(2)用不同浓度的FSH刺激卵巢癌Hey细胞不同时间,采用蛋白质印迹法检测细胞内Nrf2蛋白的表达.(3)采用ROS检测试剂盒检测80 mIU/ml的FSH刺激后不同时间Hey细胞内ROS的生成情况.(4)Hey细胞经不同浓度的H2O2刺激48 h后,或经ROS特异性抑制剂N-乙酰半胱氨酸(NAC)预处理后加入150 mmol/L的H2O2处理48 h,观察细胞内Nrf2的表达.(5)Hey细胞经不同浓度的NAC预处理1h,加入80 mIU/ml的FSH共孵育48 h,观察细胞内Nrf2表达的变化.结果 (1)10例良性卵巢囊肿组织中仅3例有Nrf2蛋白的弱阳性表达,而64例卵巢癌组织中42例(65.6％)有Nrf2蛋白的阳性表达,两组差异有统计学意义(P=0.042).(2)FSH可上调Hey细胞内Nrf2的表达,并呈一定的剂量、时间依赖效应.(3) FSH可促进Hey细胞ROS的产生.(4) H2O2可诱导Hey细胞Nrf2蛋白的表达,且其作用可被NAC阻断.(5)NAC可阻断FSH所诱导的Nrf2蛋白的表达.结论 FSH可促进卵巢癌Hey细胞中ROS产生,上调Nrf2蛋白表达,抑制ROS途径可阻断FSH诱导的Nrf2高表达.提示FSH可能通过ROS途径调控卵巢癌Nrf2的表达,进而促进肿瘤发生.
- [1]Kensler TW,Wakabayashi N,Biswal S.Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.[J].2007,47.
- [2]B V, Stadel.Letter: The etiology and prevention of ovarian cancer.[J].1975,123.
- [3]Gina M. DeNicola,Florian A. Karreth,Timothy J. Humpton,etc.Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis[J].2011,475(Jul.7 TN.7354).
- [4]Jiang T,Zheng W,Zhao F,etc.High levels of Nrf2 determine chemoresistance in type II endometrial cancer.[J].2010,70(13).
- [5]Won JS,Singh I.Sphingolipid signaling and redox regulation.[J].2006,40(11).
- [6]Sporn MB,Liby KT.Cancer chemoprevention: scientific promise, clinical uncertainty.[J].2005,2(10).
- [7]Hernandez Garcia D,Wood CD,Castro Obregon S,etc.Reactive oxygen species: A radical role in development?[J].2010,49(2).
- [8]Dinkova-Kostova AT,Wakabayashi N,Holtzclaw WD,etc.Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers[J].2004,101(7).
- [9]Kaaks R,Lukanova A.Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.[J].2005,14(1).
- [10]Holschneider CH,Berek JS.Ovarian cancer: epidemiology, biology, and prognostic factors.[J].2000,19(1).
- [11]Manandhar S,Lee S,Kwak MK.Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.[J].2010,33(5).
- [12]Jong-Min Lee,Jeffrey A. Johnson.An Important Role of Nrf2-ARE Pathway in the Cellular Defense Mechanism[J].2004,37(2).
- [13]Gius D,Wink DA,Russo A,etc.Oxidative stress, redox, and the tumor microenvironment.[J].2004,14(3).
- [14]Toniolo P.Serum Follicle-Stimulating Hormone and Risk of Epithelial Ovarian Cancer in Postmenopausal Women.[J].2003,12(12).
- [15]Ning, Chen,Xiaofang, Yi,Nisreen, Abushahin,etc.Nrf2 expression in endometrial serous carcinomas and its precancers.[J].2010,4(1).